Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
PUT
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$34.2M
| $5.36M | ﹤0.01% |
28,900
-46,600
| -62% | -$7.68M |
2021 Q4
3 quarters
|
|
3677
PUT
Waters Corp
WAT
$42.9B
| $5.36M | ﹤0.01% |
19,900
+3,700
| +23% | +$1.18M |
2013 Q2
37 quarters
|
|
3678
CALL
Republic Services
RSG
$65.8B
| $5.36M | ﹤0.01% |
39,400
+13,700
| +53% | +$1.91M |
2018 Q1
18 quarters
|
|
3679
Arch Capital
ACGL
$32.4B
| $5.36M | ﹤0.01% |
117,594
-227,631
| -66% | -$10.3M |
2019 Q4
11 quarters
|
|
|
ICVX
3680
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $5.35M | ﹤0.01% |
1,693,734
+126,026
| +8% | +$788K |
2021 Q3
4 quarters
|
|
3681
PUT
DXC Technology
DXC
$1.89B
| $5.35M | ﹤0.01% |
218,600
+142,800
| +188% | +$3.93M |
2017 Q2
21 quarters
|
|
3682
CALL
iShares Core US Aggregate Bond ETF
AGG
$136B
| $5.35M | ﹤0.01% |
55,500
+7,500
| +16% | +$758K |
2020 Q2
9 quarters
|
|
|
UCTT
3683
Ultra Clean Holdings
UCTT
$3.32B
| $5.35M | ﹤0.01% |
207,648
+29,095
| +16% | +$891K |
2020 Q1
10 quarters
|
|
3684
CALL
iShares MSCI India ETF
INDA
$5.82B
| $5.34M | ﹤0.01% |
131,000
-84,400
| -39% | -$3.56M |
2017 Q3
20 quarters
|
|
3685
Recursion Pharmaceuticals
RXRX
$2.48B
| $5.34M | ﹤0.01% |
501,870
+194,498
| +63% | +$1.97M |
2021 Q4
3 quarters
|
|
3686
Chubb
CB
$129B
| $5.34M | ﹤0.01% |
+29,348
| New | +$5.57M |
2022 Q3
0 quarters
|
|
3687
CryoPort
CYRX
$902M
| $5.33M | ﹤0.01% |
+218,889
| New | +$7.53M |
2022 Q3
0 quarters
|
|
3688
CALL
Teleflex
TFX
$5.29B
| $5.32M | ﹤0.01% |
26,400
-8,600
| -25% | -$2.06M |
2021 Q1
6 quarters
|
|
3689
CALL
First Horizon
FHN
$11.1B
| $5.3M | ﹤0.01% |
231,500
-56,100
| -20% | -$1.27M |
2016 Q3
24 quarters
|
|
3690
Boise Cascade
BCC
$2.63B
| $5.3M | ﹤0.01% |
89,093
-33,445
| -27% | -$2.15M |
2017 Q3
20 quarters
|
|
|
KIII
3691
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $5.3M | ﹤0.01% |
535,065
-430
| -0.1% | -$4.24K |
2021 Q2
5 quarters
|
|
3692
Cloudflare
NET
$126B
| $5.29M | ﹤0.01% |
95,647
-239,750
| -71% | -$14.2M |
2019 Q3
12 quarters
|
|
3693
Credicorp
BAP
$30.6B
| $5.29M | ﹤0.01% |
43,081
-6,087
| -12% | -$780K |
2020 Q3
8 quarters
|
|
3694
Johnson & Johnson
JNJ
$614B
| $5.29M | ﹤0.01% |
32,385
-314,421
| -91% | -$53.2M |
2017 Q3
20 quarters
|
|
|
OSG
3695
CALL
Octave Specialty Group
OSG
$208M
| $5.29M | ﹤0.01% |
414,800
+325,500
| +365% | +$4.34M |
2018 Q1
18 quarters
|
|
3696
PUT
PTC Therapeutics
PTCT
$5.32B
| $5.29M | ﹤0.01% |
105,300
-20,300
| -16% | -$995K |
2022 Q2
1 quarter
|
|
3697
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $5.29M | ﹤0.01% |
138,522
+5,015
| +4% | +$218K |
2021 Q4
3 quarters
|
|
3698
State Street SPDR S&P Homebuilders ETF
XHB
$1.45B
| $5.29M | ﹤0.01% |
+96,647
| New | +$5.86M |
2022 Q3
0 quarters
|
|
|
CMRX
3699
DELISTED
Chimerix, Inc.
CMRX
| $5.28M | ﹤0.01% |
2,734,561
+2,717,322
| +15,763% | +$6.1M |
2013 Q4
35 quarters
|
|
3700
CALL
TG Therapeutics
TGTX
$7.99B
| $5.28M | ﹤0.01% |
891,200
+144,300
| +19% | +$946K |
2017 Q1
22 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.